Difference between revisions of "Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x) (Q10754)"

Latest revision as of 22:21, 20 October 2020

Publication: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic"published as Crit Care; 2020 04 28 ; 24 (1) 176; DOI: 10.1186/s13054-020-02882-x

Language	Label	Description	Also known as
English	Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x)	Publication: "COVID-19: ICU delirium management during SARS-CoV-2 pandemic"published as Crit Care; 2020 04 28 ; 24 (1) 176; DOI: 10.1186/s13054-020-02882-x

Statements

instance of

Segment

0 references

occurs in

COVID-19: ICU delirium management during SARS-CoV-2 pandemic (DOI: 10.1186/s13054-020-02882-x)

0 references

part of

COVID-19: ICU delirium management during SARS-CoV-2 pandemic (DOI: 10.1186/s13054-020-02882-x)

0 references

IMRaD(C) Section

Introduction

0 references

Section or subsection level in publication

Main section in publication

0 references

Has Sectioning

Section 1: Introduction (from DOI: 10.1186/s13054-020-02882-x)

0 references

Section 2: COVID-19: Potential factors contributing to ICU delirium (from DOI: 10.1186/s13054-020-02882-x)

0 references

Section 3: COVID-19: Neuro-invasive potential of SARS-nCoV-2 as cause of delirium (from DOI: 10.1186/s13054-020-02882-x)

0 references

Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x)

0 references

Section 5: Conclusions (from DOI: 10.1186/s13054-020-02882-x)

0 references

Authors' contributions (from DOI: 10.1186/s13054-020-02882-x)

0 references

Funding (from DOI: 10.1186/s13054-020-02882-x)

0 references

Availability of data and materials (from DOI: 10.1186/s13054-020-02882-x)

0 references

Ethics approval and consent to participate (from DOI: 10.1186/s13054-020-02882-x)

0 references

Consent for publication (from DOI: 10.1186/s13054-020-02882-x)

0 references

Competing interests (from DOI: 10.1186/s13054-020-02882-x)

0 references

References (from DOI: 10.1186/s13054-020-02882-x)

0 references

named entity

Delirium (disease - MeSH descriptor)

0 references

Human (species)

0 references

Cardiac Death (disease - MeSH descriptor)

0 references

Dementia (disease - MeSH descriptor)

0 references

glycoprotein hormone subunit alpha 2 (gene)

0 references

sphingolipid transporter 1 (putative) (gene)

0 references

Coronaviridae (species)

0 references

gamma-Aminobutyric Acid (chemical - MeSH descriptor)

0 references

Propofol (chemical - MeSH descriptor)

0 references

Pain (disease - MeSH descriptor)

0 references

Stress Disorders, Post-Traumatic (disease - MeSH descriptor)

0 references

Peripheral Nervous System Diseases (disease - MeSH descriptor)

0 references

Paralysis (disease - MeSH descriptor)

0 references

Psychomotor Agitation (disease - MeSH descriptor)

0 references

Cross Infection (disease - MeSH descriptor)

0 references

Movement Disorders (disease - MeSH descriptor)

0 references

Olfaction Disorders (disease - MeSH descriptor)

0 references

Heart Failure (disease - MeSH descriptor)

0 references

Popliteal Pterygium Syndrome, Lethal Type (disease - MeSH supplementary concept)

0 references

2019 novel coronavirus (species)

0 references

Critical Illness (disease - MeSH descriptor)

0 references

Respiratory Insufficiency (disease - MeSH descriptor)

0 references

Constipation (disease - MeSH descriptor)

0 references

Hyperkinesis (disease - MeSH descriptor)

0 references

Collection or Dataset of Origin

Pubtator Central BioC-JSON formatted article files

0 references

Sitelinks

⧼wikibase-sitelinks-sliswiki⧽(1 entry)

sliswiki Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x)

@@ Property / named entity @@
-COVID-19 (disease - MeSH supplementary concept)
@@ Property / named entity: COVID-19 (disease - MeSH supplementary concept) / rank @@
-Normal rank
@@ Property / named entity @@
+sphingolipid transporter 1 (putative) (gene)
@@ Property / named entity: sphingolipid transporter 1 (putative) (gene) / rank @@
+Normal rank
@@ Property / named entity @@
+Coronaviridae (species)
@@ Property / named entity: Coronaviridae (species) / rank @@
+Normal rank
@@ Property / named entity @@
+gamma-Aminobutyric Acid (chemical - MeSH descriptor)
+Normal rank
@@ Property / named entity @@
+Propofol (chemical - MeSH descriptor)
@@ Property / named entity: Propofol (chemical - MeSH descriptor) / rank @@
+Normal rank
@@ Property / named entity @@
+Pain (disease - MeSH descriptor)
@@ Property / named entity: Pain (disease - MeSH descriptor) / rank @@
+Normal rank
@@ Property / named entity @@
+Stress Disorders, Post-Traumatic (disease - MeSH descriptor)
+Normal rank
@@ Property / named entity @@
+Peripheral Nervous System Diseases (disease - MeSH descriptor)
+Normal rank
@@ Property / named entity @@
+Paralysis (disease - MeSH descriptor)
@@ Property / named entity: Paralysis (disease - MeSH descriptor) / rank @@
+Normal rank
@@ Property / named entity @@
+Psychomotor Agitation (disease - MeSH descriptor)
+Normal rank
@@ Property / named entity @@
+Cross Infection (disease - MeSH descriptor)
@@ Property / named entity: Cross Infection (disease - MeSH descriptor) / rank @@
+Normal rank
@@ Property / named entity @@
+Movement Disorders (disease - MeSH descriptor)
@@ Property / named entity: Movement Disorders (disease - MeSH descriptor) / rank @@
+Normal rank
@@ Property / named entity @@
+Olfaction Disorders (disease - MeSH descriptor)
@@ Property / named entity: Olfaction Disorders (disease - MeSH descriptor) / rank @@
+Normal rank
@@ Property / named entity @@
+Heart Failure (disease - MeSH descriptor)
@@ Property / named entity: Heart Failure (disease - MeSH descriptor) / rank @@
+Normal rank
@@ Property / named entity @@
+Popliteal Pterygium Syndrome, Lethal Type (disease - MeSH supplementary concept)
+Normal rank
@@ Property / named entity @@
+novel coronavirus (species)
@@ Property / named entity: 2019 novel coronavirus (species) / rank @@
+Normal rank
@@ Property / named entity @@
+Critical Illness (disease - MeSH descriptor)
@@ Property / named entity: Critical Illness (disease - MeSH descriptor) / rank @@
+Normal rank
@@ Property / named entity @@
+Respiratory Insufficiency (disease - MeSH descriptor)
+Normal rank
@@ Property / named entity @@
+Constipation (disease - MeSH descriptor)
@@ Property / named entity: Constipation (disease - MeSH descriptor) / rank @@
+Normal rank
@@ Property / named entity @@
+Hyperkinesis (disease - MeSH descriptor)
@@ Property / named entity: Hyperkinesis (disease - MeSH descriptor) / rank @@
+Normal rank
@@ Property / Collection or Dataset of Origin @@
+Pubtator Central BioC-JSON formatted article files
+Normal rank

Difference between revisions of "Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x) (Q10754)"

Latest revision as of 22:21, 20 October 2020

Statements

Sitelinks

⧼wikibase-sitelinks-sliswiki⧽(1 entry)

Navigation menu

Personal tools

Namespaces

Variants

Views

More

Search

Navigation

Tools

In other languages